These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 38652364)

  • 1. Role of the RAAS in mediating the pathophysiology of COVID-19.
    Jasiczek J; Doroszko A; Trocha T; Trocha M
    Pharmacol Rep; 2024 Jun; 76(3):475-486. PubMed ID: 38652364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation.
    Augustine R; S A; Nayeem A; Salam SA; Augustine P; Dan P; Maureira P; Mraiche F; Gentile C; Hansbro PM; McClements L; Hasan A
    Chem Biol Interact; 2022 Jan; 351():109738. PubMed ID: 34740598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2.
    Young MJ; Clyne CD; Chapman KE
    J Endocrinol; 2020 Nov; 247(2):R45-R62. PubMed ID: 32966970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID-19 disease.
    Khoury EE; Knaney Y; Fokra A; Kinaneh S; Azzam Z; Heyman SN; Abassi Z
    J Cell Mol Med; 2021 Apr; 25(8):3840-3855. PubMed ID: 33660945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.
    Beyerstedt S; Casaro EB; Rangel ÉB
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):905-919. PubMed ID: 33389262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review.
    Ingraham NE; Barakat AG; Reilkoff R; Bezdicek T; Schacker T; Chipman JG; Tignanelli CJ; Puskarich MA
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32341103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2, ACE2 expression, and systemic organ invasion.
    Ashraf UM; Abokor AA; Edwards JM; Waigi EW; Royfman RS; Hasan SA; Smedlund KB; Hardy AMG; Chakravarti R; Koch LG
    Physiol Genomics; 2021 Feb; 53(2):51-60. PubMed ID: 33275540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system.
    Rysz S; Al-Saadi J; Sjöström A; Farm M; Campoccia Jalde F; Plattén M; Eriksson H; Klein M; Vargas-Paris R; Nyrén S; Abdula G; Ouellette R; Granberg T; Jonsson Fagerlund M; Lundberg J
    Nat Commun; 2021 Apr; 12(1):2417. PubMed ID: 33893295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19.
    Haslbauer JD; Stalder A; Zinner C; Bassetti S; Mertz KD; Went P; Matter M; Tzankov A
    Pathobiology; 2022; 89(3):166-177. PubMed ID: 34915500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19.
    Rieder M; Wirth L; Pollmeier L; Jeserich M; Goller I; Baldus N; Schmid B; Busch HJ; Hofmann M; Kern W; Bode C; Duerschmied D; Lother A
    Am J Hypertens; 2021 Apr; 34(3):278-281. PubMed ID: 33043967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications.
    Groß S; Jahn C; Cushman S; Bär C; Thum T
    J Mol Cell Cardiol; 2020 Jul; 144():47-53. PubMed ID: 32360703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.
    Kutz A; Conen A; Gregoriano C; Haubitz S; Koch D; Domenig O; Bernasconi L; Mueller B; Schuetz P
    Eur J Endocrinol; 2021 Apr; 184(4):543-552. PubMed ID: 33539316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors and Coronavirus Disease 2019 (COVID-19).
    Albashir AAD
    South Med J; 2021 Jan; 114(1):51-56. PubMed ID: 33398362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS).
    Cadegiani FA; Goren A; Wambier CG
    Med Hypotheses; 2020 Oct; 143():110112. PubMed ID: 32721806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical dependency of the SARS-CoV-2 virus and the renin-angiotensin-aldosterone (RAAS) axis: a possible new threat.
    Sen R; Sengupta D; Mukherjee A
    Environ Sci Pollut Res Int; 2022 Sep; 29(41):62235-62247. PubMed ID: 34859345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of renin-angiotensin-aldosterone system inhibitors on organ-specific ace2 expression in zebrafish and its implications for COVID-19.
    Kim GJ; Melgoza A; Jiang F; Guo S
    Sci Rep; 2021 Dec; 11(1):23670. PubMed ID: 34880395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations.
    Maranduca MA; Vamesu CG; Tanase DM; Clim A; Drochioi IC; Pinzariu AC; Filip N; Dima N; Tudorancea I; Serban DN; Serban IL
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression.
    Zlacká J; Stebelová K; Zeman M; Herichová I
    Physiol Res; 2021 Dec; 70(S2):S177-S194. PubMed ID: 34913351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAAS Blockade and COVID-19: Mechanistic Modeling of Mas and AT1 Receptor Occupancy as Indicators of Pro-Inflammatory and Anti-Inflammatory Balance.
    Melissa Hallow K; Dave I
    Clin Pharmacol Ther; 2021 Apr; 109(4):1092-1103. PubMed ID: 33506503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.